Key result
Cancer is linked to ~144% higher long-term mortality in PE patients despite similar in-hospital survival.
Why the study?
Does multidisciplinary PERT management yield different clinical outcomes in oncologic patients compared to nononcologic patients with pulmonary embolism?
Cohort (n=235)
Yes
Does multidisciplinary PERT management yield different clinical outcomes in oncologic patients compared to nononcologic patients with pulmonary embolism?
Multidisciplinary PERT management for pulmonary embolism in cancer patients achieves in-hospital survival rates comparable to non-cancer patients, though long-term mortality remains higher due to the underlying malignancy.
Answers are grounded in this paper and cite their sources.
Comparable in-hospital survival supports PERT consideration in cancer-associated PE; leaves open long-term risk modification.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Pietrasik et al. (2023) conducted a cohort in Pulmonary embolism (n=235). Oncologic status (Cancer) vs. Nononcologic status (No cancer) was evaluated on Long-term mortality (HR 2.44, 95% CI 1.51-3.95, p=<0.001). Cancer was associated with a significantly increased risk of long-term mortality (HR 2.44) in patients with pulmonary embolism, despite similar in-hospital survival rates compared to nononcologic patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: